| Literature DB >> 14738389 |
Dennis J Milanowski1, Kirk R Gustafson, James A Kelley, James B McMahon.
Abstract
An extract of the marine bryozoan Caulibugula intermis, collected in the Indo-Pacific off Palau, produced a distinct pattern of differential cytotoxicity in the National Cancer Institute's 60 cell line antitumor screen. Bioactivity-directed fractionation of the extract provided six new compounds, caulibugulones A-F (1-6). The structures of these novel metabolites were determined by spectrochemical analyses including LC-MS, HRFABMS, 1-D and 2-D NMR experiments, and by comparison with related compounds. The structures of compounds 2 and 3 were confirmed by chemical interconversion. The isolated compounds exhibited IC(50)'s of 0.03-1.67 microg/mL against murine tumor cells in an in vitro cytotoxicity assay.Entities:
Mesh:
Substances:
Year: 2004 PMID: 14738389 DOI: 10.1021/np030378l
Source DB: PubMed Journal: J Nat Prod ISSN: 0163-3864 Impact factor: 4.050